Firms
Theme

SIGI

Selective Insurance Group · NASDAQ

News

7 latest

Zacks Investment Research

Here's What Key Metrics Tell Us About Selective Insurance (SIGI) Q3 Earnings

Selective Insurance reported Q3 2026 revenue of $1.35 billion (down 0.5% YoY) with EPS of $2.37, significantly beating the consensus estimate of $1.91 (+24.08%). The company's combined ratio of 96.8% beat analyst expectations of 100%, and net investment income grew 15.7% YoY to $160.5 million. However, net premiums earned declined 2% YoY, and the stock holds a Zacks Rank #3 (Hold) rating.

Zacks Investment Research

Selective Insurance (SIGI) Q3 Earnings Top Estimates

Selective Insurance (SIGI) reported quarterly earnings of $2.37 per share, significantly beating the consensus estimate of $1.91 per share, representing a 24.08% earnings surprise. However, revenues of $1.35 billion slightly missed expectations by 0.6%.

Zacks Investment Research

Stay Ahead of the Game With Selective Insurance (SIGI) Q3 Earnings: Wall Street's Insights on Key Metrics

Selective Insurance (SIGI) is expected to report Q3 earnings of $1.91 per share, up 9.1% year-over-year, with revenues forecast at $1.35 billion. While net premiums earned are projected to decline slightly by 1.3%, net investment income is expected to grow 11.9%.

Zacks Investment Research

Why Selective Insurance (SIGI) is a Top Momentum Stock for the Long-Term

Selective Insurance Group (SIGI), a property & casualty insurer established in 1926, is highlighted as a momentum stock worth watching. The company holds a #3 (Hold) Zacks Rank with an A VGM Score and B Momentum Style Score. Two analysts raised earnings estimates in the last 60 days, with consensus estimates increasing to $8.20 per share, and the stock has gained 2.8% over the past four weeks.

Zacks Investment Research

Selective Insurance (SIGI) Reports Next Week: Wall Street Expects Earnings Growth

Selective Insurance is expected to report Q3 2026 earnings on October 22 with consensus EPS of $1.91 (up 9.1% YoY) and revenues of $1.35 billion (up 0.1% YoY). The company has a positive Earnings ESP of +3.28% combined with a Zacks Rank #3, suggesting it will likely beat consensus estimates. The company has beaten EPS estimates in 2 of the last 4 quarters, with the most recent quarter delivering a +13.37% surprise.

Zacks Investment Research

Selective Insurance (SIGI) Could Be a Great Choice

Selective Insurance (SIGI) is highlighted as an attractive dividend investment opportunity for income-focused investors. The company offers a 2.04% dividend yield, significantly higher than its industry average of 0.96%, with an annualized dividend of $1.72 that has grown 11.15% annually over the past 5 years. With a conservative 22% payout ratio and expected earnings growth of 10.03% for 2026, SIGI presents a balanced opportunity combining income generation with growth potential, though it carries a Zacks Rank of #3 (Hold).

Zacks Investment Research

Here's Why Selective Insurance (SIGI) is a Strong Growth Stock

Selective Insurance Group, Inc. (SIGI) is featured as a stock to watch with a #3 (Hold) Zacks Rank and an A VGM Score. The company demonstrates strong growth potential with a B Growth Style Score and forecasted 10% year-over-year earnings growth. Two analysts recently raised their fiscal 2026 earnings estimates to $8.12 per share, and the company has a +5.2% average earnings surprise.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $SIGI · 0 threads

Sign in to post on $SIGI

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev